Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference10 articles.
1. Chiew CJ, Wei WE, Ong B, et al. Vaccine Effectiveness against COVID-19 Infection among 12 to 18 year olds in Singapore. SSRN. Preprint posted online January 8, 2022. doi: 10.2139/ssrn.3996796
2. Dorabawila V, Hoefer D, Bauer UE, et al. Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant. medRxiv. Preprint posted online February 28, 2022. doi: 10.1101/2022.02.25.22271454
3. Safety, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents;Frenck;N Engl J Med,2021
4. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
5. Effectiveness of BNT162b2 vaccine against critical COVID-19 in adolescents;Olson;N Engl J Med,2022
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assessing the dynamics and impact of COVID-19 vaccination on disease spread: A data-driven approach;Infectious Disease Modelling;2024-06
2. Effectiveness of COVID-19 vaccines among children 6–11 years against hospitalization during Omicron predominance in Malaysia;Scientific Reports;2024-03-08
3. Willingness and understanding of the safety and effectiveness of COVID‐19 vaccines in young children: a cross‐sectional study among parents in Malaysia;Journal of Pharmacy Practice and Research;2024-02-14
4. Efficacy and Safety of COVID-19 Vaccines in Adolescents: Systematic Review of Randomized Controlled Studies and Observational Studies;Pediatric Infection & Vaccine;2024
5. Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review;Frontiers in Public Health;2023-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3